OncoMed Pharmaceuticals Inc

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$38.7M

765 transactions

Summary

OncoMed Pharmaceuticals Inc is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $23.3MSales: $14.9M47 insiders

Date	Insider	Type	Value
2018-12-24	Gurney Austin(See Remarks)	Sell	$7K
2018-10-09	Lewicki John A.(President & CEO)	Sell	$5K
2018-10-09	Hager Alicia J.(SVP & General Counsel)	Sell	$4K
2018-10-09	Stagg Robert(SVP, Clinical R&D)	Sell	$4K
2018-10-10	Hager Alicia J.(SVP & General Counsel)	Sell	$2K
2018-10-10	Lewicki John A.(President & CEO)	Sell	$2K
2018-10-10	Gurney Austin(See Remarks)	Sell	$2K
2018-10-10	Li Yvonne(See Remarks)	Sell	$2K
2018-10-10	Stagg Robert(SVP, Clinical R&D)	Sell	$2K
2019-04-23	KARSEN PERRY A	U	—
2019-04-23	Stagg Robert(See Remarks)	U	—
2019-04-23	Li Yvonne(See Remarks)	U	—
2019-04-23	PAKIANATHAN DEEPIKA	U	—
2019-04-23	PAKIANATHAN DEEPIKA	U	—
2019-04-23	Lewicki John A.(President and CEO)	U	—
2019-04-23	LASERSOHN JACK W	U	—
2019-04-23	LASERSOHN JACK W	U	—
2019-04-23	LASERSOHN JACK W	U	—
2019-04-23	ROOT JONATHAN D	U	—
2019-04-23	Hager Alicia J.(SVP and General Counsel)	U	—

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

OncoMed Pharmaceuticals Inc — Contributions, Lobbying & Contracts | Poliscope